Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.64 |
| ▸ | LMNA | P02545 | 1/20 | 0.64 |
| ▸ | RAB9A | P51151 | 8/20 | 0.50 |
| ▸ | NPC1 | O15118 | 6/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.42 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.42 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10000252 | 0.88 | ALDH1A1 (0.72) | SMN1; SMN2ALDH1A1LMNARAB9ANPC1 | |
| SCHEMBL31073516 | 0.83 | ALDH1A1 (0.43) | SMN1; SMN2ALDH1A1LMNARAB9ANPC1 | |
| SCHEMBL26523431 | 0.83 | ALDH1A1 (0.46) | SMN1; SMN2ALDH1A1LMNARAB9ANPC1 | |
| SCHEMBL9264165 | 0.83 | KDM4E (0.60) | SMN1; SMN2ALDH1A1LMNARAB9ANPC1 | |
| SCHEMBL14117651 | 0.83 | ALDH1A1 (0.55) | SMN1; SMN2ALDH1A1LMNARAB9ANPC1 | |
| SCHEMBL17184682 | 0.83 | ALDH1A1 (0.46) | SMN1; SMN2ALDH1A1LMNARAB9ANPC1 | |
| SCHEMBL17184845 | 0.83 | CA1 (0.49) | SMN1; SMN2ALDH1A1LMNARAB9ANPC1 | |
| SCHEMBL14970084 | 0.83 | NPC1 (0.50) | SMN1; SMN2ALDH1A1LMNARAB9ANPC1 | |
| SCHEMBL2421712 | 0.82 | ALDH1A1 (0.57) | SMN1; SMN2ALDH1A1LMNARAB9ANPC1 | |
| SCHEMBL23329317 | 0.81 | SMN1; SMN2 (0.46) | SMN1; SMN2ALDH1A1LMNARAB9ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240021012-A1 | FINGERPRINT RECOGNITION SENSOR AND OPTICAL ELEMENT | FUJIFILM CORPORATION (JP) | 2024-01-18 | — | — | US | disclosed |
| US-11806335-B2 | Heterocyclic carboxylate compounds as glycolate oxidase inhibitors | Lilac Therapeutics, Inc. (US) | 2023-11-07 | — | — | US | disclosed |
| US-20230321091-A1 | SUBSTITUTED PYRIDAZINONES FOR USE IN THE TREATMENT OF NEUROMUSCULAR DISEASES | EDGEWISE THERAPEUTICS, INC. | 2023-10-12 | — | — | US | disclosed |
| CN-111995620-B | Preparation method of 1,3, 4-thiadiazole compound and compound prepared by same | 重庆医科大学 | 2023-06-06 | — | — | CN | disclosed |
| US-20210128532-A1 | HETEROCYCLIC CARBOXYLATE COMPOUNDS AS GLYCOLATE OXIDASE INHIBITORS | Lilac Therapeutics, Inc. | 2021-05-06 | — | — | US | disclosed |
| CN-111995620-A | Preparation method of 1,3, 4-thiadiazole compound and compound prepared by same | 重庆医科大学 | 2020-11-27 | — | — | CN | disclosed |
| US-20130200306-A1 | SYNERGISTIC HOST-GUEST INTERACTIONS IN FLC MIXTURES FOR INCREASED POLARIZATION AND DECREASED SWITCHING SPEED | MICRON TECHNOLOGY, INC. (US) | 2013-08-08 | — | — | US | disclosed |
| US-20130172558-A1 | NAPROXEN-BASED CHIRAL COMPOUNDS AND LIQUID CRYSTAL DISPLAY APPLICATIONS | CITIZEN FINETECH MIYOTA CO., LTD. (JP) | 2013-07-04 | — | — | US | disclosed |
| US-8420686-B2 | Linked diimidazole antivirals | ENANTA PHARMACEUTICALS, INC. (US) | 2013-04-16 | — | — | US | disclosed |
| US-8388860-B2 | Chiral compounds, liquid crystal compositions and polymer networks derived therefrom | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-03-05 | — | — | US | disclosed |
| US-20090161061-A1 | Multilayer laminates comprising chiral nematic liquid crystals | E. I. DU PONT DE NEMOURS AND COMPANY | 2009-06-25 | — | — | US | disclosed |
| US-7534371-B2 | Liquid crystalline compound, liquid crystalline composition and retardation film | FUJIFILM CORPORATION (JP) | 2009-05-19 | — | — | US | disclosed |
| US-7443900-B2 | Laser gain medium for solid state dye lasers | BASF AKTIENGESELLSCHAFT (DE) | 2008-10-28 | — | — | US | disclosed |
| US-7443900-B2 | Laser gain medium for solid state dye lasers | BASF AKTIENGESELLSCHAFT (DE) | 2008-10-28 | — | — | US | disclosed |
| US-20080186443-A1 | Liquid Crystal Composition, Retardation Plate, and Elliptic Polarizing Plate | FUJIFILM CORPORATION (JP) | 2008-08-07 | — | — | US | disclosed |
| US-20080169448-A1 | Liquid crystalline compound, liquid crystalline composition and retardation film | FUJIFILM CORPORATION (JP) | 2008-07-17 | — | — | US | disclosed |
| US-7364670-B2 | Liquid crystalline compound, liquid crystalline composition and retardation film | FUJIFILM CORPORATION (JP) | 2008-04-29 | — | — | US | disclosed |
| EP-1092721-B1 | Chiral glucosides and their use as chiral dopants for the production of cholesteric liquid crystalline compositions | BASF AG (DE) | 2007-12-19 | — | — | EP | disclosed |
| US-7258902-B2 | Chiral 3,4-dihydro-2H-pyran compounds | BASF AKTIENGESELLSCHAFT (DE) | 2007-08-21 | — | — | US | disclosed |
| US-7258902-B2 | Chiral 3,4-dihydro-2H-pyran compounds | BASF AKTIENGESELLSCHAFT (DE) | 2007-08-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080169448-A1 | Liquid crystalline compound, liquid crystalline composition and retardation film | NCAPD2, RCC1, CCND2 | SMN1; SMN2 4507/4885ALDH1A1 4792/4885LMNA 496/4885 |
| US-20230321091-A1 | SUBSTITUTED PYRIDAZINONES FOR USE IN THE TREATMENT OF NEUROMUSCULAR DISEASES | IL6, MUSK, SMN1; SMN2 | SMN1; SMN2 3/4885ALDH1A1 308/4885LMNA 340/4885 |
| US-20130172558-A1 | NAPROXEN-BASED CHIRAL COMPOUNDS AND LIQUID CRYSTAL DISPLAY APPLICATIONS | CRY1, CRY2, ALOX5 | SMN1; SMN2 3451/4885ALDH1A1 1781/4885LMNA 2839/4885 |
| US-11806335-B2 | Heterocyclic carboxylate compounds as glycolate oxidase inhibitors | UGDH, PGD, PNPO | SMN1; SMN2 4237/4885ALDH1A1 184/4885LMNA 4767/4885 |
| US-20210128532-A1 | HETEROCYCLIC CARBOXYLATE COMPOUNDS AS GLYCOLATE OXIDASE INHIBITORS | UGDH, PGD, PNPO | SMN1; SMN2 4237/4885ALDH1A1 184/4885LMNA 4767/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.